"Great Apes (chimpanzees, gorillas, pygmy gorillas and orang-utans) have never been used under the [Animals (Scientific Procedures)] 1986 Act as laboratory animals. But this has not previously been banned. The Government will not allow their use in the future. This is a matter of morality. The cognitive and behavioural characteristics and qualities of these animals mean it is unethical to treat them as expendable for research."
Ms Hillier said that "there are no plans to change this policy", adding that the then Government's position was that "the current revision of the Directive [Directive 86/609/EEC] should aim to improve the regulation of animal use by focusing on key areas where regulation and harmonisation would improve animal welfare, improve scientific outputs, provide a more level playing field within the EU and improve the EU's competitiveness with other economic regions without compromising science and welfare."
That the use of great apes in laboratories in the UK is not specifically banned by law has long been seen as a weakness, especially as organisations such as the Research Defence Society (which has merged with the Coalition for Medical Progress to form Understanding Animal Research [UAR], and individuals such as Professor Colin Blakemore 2,3 and Professor Tipu Aziz, 4 have repeatedly argued that the possibility of their use under certain circumstances should be kept open, albeit without explaining why or how. 5, 6 Our ongoing concern was heightened by the inclusion in Directive 2010/63/EU, 7 the replacement for Directive 86/609/EEC, of articles which ban the use of great apes (Article 8 [3] ), but would permit Member States to seek a derogation from the Commission to bypass the ban and permit their use, in circumstances where it could be considered essential (Article 55 [2] ).
This was discussed by the All Party Parliamentary Group for the Replacement of Animals in Medical Experimentation (APPRG), for which FRAME provides the Secretariat. The Chairman of the Group, Nic Dakin MP, then wrote to the Home Office Minister, Lynne Featherstone MP, to suggest that the UK's current position against the use of great apes would be weakened, if the Government did not take advantage of another article in the Directive (Article 2), which permits the Member States to maintain stricter measures, by putting a ban on the face of the revised UK legislation. At about the same time, the British Union for the Abolition of Vivisection (BUAV) and FRAME made a joint submission to the Government, spelling out the irrefutable ethical welfare, scientific and logistical reasons why the ban should be made legally binding in the UK. 8 Unfortunately, in her replies to both the APPRG and BUAV/FRAME, Lynne Featherstone said that, while the Government could not foresee any circumstances in which the use of great apes would be permitted in UK laboratories, the intention was to copy the derogation clause in the Directive directly into the revised UK legislation.
This point was raised again by Nic Dakin a few weeks later, when he led a Westminster Hall Debate on the new EU Directive, 9 and we were all surprised when Damian Green MP, another Home Office Minister, standing in for Lynne Featherstone, said, "We will continue to prohibit the use of great apes. There has been concern -the hon. Gentleman expressed it earlier -that the Directive weakens the protection of those animals by providing a derogation allowing their use in exceptional circumstances. I can assure him and the House that we foresee no circumstances in which we would use that derogation, and we will put the ban in the legislation, as he asked. That is a full assurance such as he sought."
After this exchange, Nic Dakin asked the Minister for clarification, and received the assurance that "our position on great apes is as set out by Damian Green in that debate". Nevertheless, when the Summary Report and Government Response 10 As if by chance, a meeting between the Minister and the APPRG had been arranged for that same day, and we were delighted when Lynne Featherstone confirmed that the ban on the use of great apes as laboratory animals in the UK would indeed be on the face of the bill for the transposition of Directive 2010/63/EU, and that new legislation would be needed, if, at some time in the future, it were proposed that the ban should be circumvented. 12 We now wait to see precisely what words will be used, when the bill is put before Parliament after the Summer Recess.
I think it is worth considering this affair in detail, as it raises some very important points. One of them is the quality of advice received by the Government and the Home Office on the complex issues with which they have to deal. Here is an example of the kind of problem with which they are faced.
Just before the Westminster Hall debate, Nic Dakin received a message from Understanding Animal Research (UAR), which referred to the use of great apes, that said, "We are... aware, for example, of recent deaths in wild gorillas due to human viruses, and so can envisage a possible need to test vaccines on such species -in other words a blanket ban can end up harming more great apes than it saves, let alone the human outbreak scenarios envisaged in this Telegraph article from 2006..., and this is therefore an opportunity to allow UK scientists to contribute to such tests." The Telegraph article referred to was yet another report on statements by Colin Blakemore, 13 and the words of the UAR message were taken from the UK Bioscience Sector Coalition (UKBSC) response to the Home Office consultation on the transposition of the Directive. 14 We can be sure that additional and even morechallenging questions would arise, if it were ever to be claimed that the use of great apes was warranted by "a life-threatening or debilitating condition endangering human beings where no other species or alternative method would suffice"also recognised by the UKBSC as a reason for not having a ban. Such a plan would be more likely to involve chimpanzees than gorillas, and, given the mountain of evidence that research on chimpanzees is not effective, efficient, or necessary in relation to human health and well-being, 8 how could it be convincingly shown, while a ban on the use of great apes was in place, that "no other species would suffice"?
The kinds of questions I have raised have been discussed at numerous conferences and in various publications over a number of decades, and it is a matter of great concern that nobody in any of the 29 organisations which endorsed the UKBSC response saw fit to see the flaws in their agreed response to the Home Office question about the use of great apes.
A superficial and generalised commitment to the Three Rs is not sufficient -reduction, refinement and replacement must be pursued and applied with rigor and with precise attention to detail, in the interests of both human well-being and animal welfare. 
Michael Balls

